Your shopping cart is currently empty

EIDD-036 is a C-20 oxime of Progesterone capable of crossing the blood-brain barrier and binding to progesterone receptors (PR) with an IC50 value of 171 nM. It is the active metabolite of EIDD-1723 and has poor water solubility, making rapid administration in acute injuries challenging. EIDD-036 is applicable for traumatic brain injury (TBI) research.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | EIDD-036 is a C-20 oxime of Progesterone capable of crossing the blood-brain barrier and binding to progesterone receptors (PR) with an IC50 value of 171 nM. It is the active metabolite of EIDD-1723 and has poor water solubility, making rapid administration in acute injuries challenging. EIDD-036 is applicable for traumatic brain injury (TBI) research. |
| In vivo | EIDD-036 is capable of effectively crossing the blood-brain barrier, achieving concentrations in brain tissue similar to those in plasma. |
| Molecular Weight | 329.48 |
| Formula | C21H31NO2 |
| Cas No. | 211302-60-2 |
| Smiles | C[C@@]12[C@]([C@]3([C@@]([C@]4(C)C(CC3)=CC(=O)CC4)(CC1)[H])[H])(CC[C@@H]2C(=NO)C)[H] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.